Direkt zum Inhalt
Merck

Design and evaluation of moxifloxacin hydrochloride ocular inserts.

Acta pharmaceutica (Zagreb, Croatia) (2012-04-05)
Pravin K Pawar, Rajesh Katara, Dipak K Majumdar
ZUSAMMENFASSUNG

The objective of the present investigation was to prepare and evaluate ocular inserts of moxifloxacin. An ocular insert was made from an aqueous dispersion of moxifloxacin, sodium alginate, polyvinyl alcohol, and dibutyl phthalate by the film casting method. The ocular insert (5.5 mm diameter) was cross-linked by CaCl2 and was coated with Eudragit S-100, RL-100, RS-100, E-100 or L-100. The in vitro drug drainage/permeation studies were carried out using an all-glass modified Franz diffusion cell. The drug concentration and mucoadhesion time of the ocular insert were found satisfactory. Cross-linking and coating with polymers extended the drainage from inserts. The cross-linked ocular insert coated with Eudragit RL-100 showed maximum drug permeation compared to other formulations.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Poly(methylmethacrylat-co-methacrylsäure), average Mw ~34,000 by GPC, average Mn ~15,000 by GPC